Shinpei Yoshida

S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters

Michihito Sasaki, Koshiro Tabata, Mai Kishimoto et al. · Science Translational Medicine · 2022 · 91 citations · Full text

Generation of intestinal organoids derived from human pluripotent stem cells for drug testing

Shinpei Yoshida, Hiroto Miwa, Tomoyuki Kawachi et al. · Scientific Reports · 2020 · 74 citations · Full text

The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro–in vivo correlation of nanocrystals

Masaaki Imono, Hiromasa Uchiyama, Shinpei Yoshida et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2019 · 47 citations

Nanoparticles, Nanomedicine, Oral Absorption Enhancement +10

Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2<i>in vitro</i>and<i>in vivo</i>

Takayuki Kuroda, Haruaki Nobori, Keita Fukao et al. · Journal of Antimicrobial Chemotherapy · 2023 · 40 citations · Full text

Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine

Takanori Akazawa, Shinpei Yoshida, Shuichi Ohnishi et al. · Drug Metabolism and Disposition · 2018 · 36 citations · Full text